Topical palmitoyl pentapeptide provides improvement in photoaged mammalian facial skin
BPC 157 treatment led to the upregulation of Egr1, Akt1, Kras, Src, Foxo, Srf, Vegfr2, Nos3, and Nos1 and the downregulation of Nos2 and Nfkb compared with untreated rats
Patients in Orange County often report feeling more vital, sleeping better, and experiencing improved overall well-being after completing their treatment protocol
No mutagenic or carcinogenic effects have been documented
Cagrilintides monotherapy evidence reaches only Phase 2: a dose-finding trial established a doseresponse on bodyweight versus placebo and versus an active comparator
"Beta-sitosterols for benign prostatic hyperplasia"